GrayBella Capital
Growth-stage investor backing European health tech and deep tech companies from Series A to C.
- Venture capital
- London
- Type
- Venture capital
- Based in
- London
- Stages
- Series A, Series B+, Growth
- Sector focus
- Healthtech, Deeptech
- Cheque size
- €1.5M–€3M
- Fund size
- Undisclosed
- Founded
- 2019
- Website
- graybellacapital.com
GrayBella Capital is a growth capital fund that invests across Europe from its London headquarters, with a further presence in Boston and team members in Spain, Lithuania and Estonia. It typically participates in Series A to Series C rounds.
The firm concentrates on two areas. In health tech it looks at diagnostics, healthcare IT, remote patient monitoring and platforms supporting drug development; in deep tech its remit covers AI and machine learning, data science, IoT, cloud and SaaS, embedded software, quantum computing and nanotechnology. Portfolio companies have included CN-Bio, BC Platforms and Sensius.
← All investors · Is this your organisation? Request an update
More investors in the directory
The Craftory
Purpose-driven consumer packaged goods brands with category-changing potential
Symvan Capital
EIS and SEIS funds backing B2B SaaS and technology companies from seed to exit
Grafton Capital
Growth capital for European software, AI and tech-enabled businesses
Blackfinch Ventures
EIS and VCT investment in early and growth-stage UK technology businesses
The Conduit Connect
Impact-led UK startups from pre-seed to Series A in climate, health and financial resilience
TrueSight Ventures
Angel-sized cheques at pre-seed and seed, sector-agnostic, into technology companies
Subscribe to Newsletter
Join me on this exciting journey as we explore the boundless world of web design together.